Latest News February 14, 2019 Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Deuterated Norketamine and Related Compounds June 1, 2018 Amorsa Therapeutics Appoints Jeffrey Wiesen to Board of Directors January 9, 2018 Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds